AG1 RELEASES LATEST UPGRADE OF ITS DAILY HEALTH DRINK, ALONGSIDE RESULTS FROM FOUR PLACEBO-CONTROLLED, RANDOMIZED CLINICAL TRIALS
AG1 commits an additional $20M to research following the launch of AG1 Next Gen, which has been clinically shown in multiple human clinical studies to close nutrient gaps and support